nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—CYP19A1—Betamethasone—atopic dermatitis	0.0886	0.136	CbGbCtD
Mefloquine—BCHE—Triamcinolone—atopic dermatitis	0.0861	0.132	CbGbCtD
Mefloquine—CYP19A1—Dexamethasone—atopic dermatitis	0.0515	0.0792	CbGbCtD
Mefloquine—CYP3A4—Pimecrolimus—atopic dermatitis	0.0434	0.0667	CbGbCtD
Mefloquine—ABCB1—Tacrolimus—atopic dermatitis	0.043	0.0662	CbGbCtD
Mefloquine—HBA2—dermis—atopic dermatitis	0.0412	0.547	CbGeAlD
Mefloquine—ABCB1—Loratadine—atopic dermatitis	0.0315	0.0484	CbGbCtD
Mefloquine—CYP2D6—Loratadine—atopic dermatitis	0.0297	0.0456	CbGbCtD
Mefloquine—CYP2D6—Diphenhydramine—atopic dermatitis	0.0297	0.0456	CbGbCtD
Mefloquine—ABCB1—Methylprednisolone—atopic dermatitis	0.0288	0.0443	CbGbCtD
Mefloquine—CYP3A4—Tacrolimus—atopic dermatitis	0.0258	0.0396	CbGbCtD
Mefloquine—CYP3A4—Loratadine—atopic dermatitis	0.0189	0.029	CbGbCtD
Mefloquine—ABCB1—Betamethasone—atopic dermatitis	0.0187	0.0288	CbGbCtD
Mefloquine—ABCB1—Prednisolone—atopic dermatitis	0.0185	0.0284	CbGbCtD
Mefloquine—ABCB1—Hydrocortisone—atopic dermatitis	0.0175	0.0269	CbGbCtD
Mefloquine—ABCB1—Prednisone—atopic dermatitis	0.0175	0.0268	CbGbCtD
Mefloquine—CYP3A4—Methylprednisolone—atopic dermatitis	0.0173	0.0265	CbGbCtD
Mefloquine—CYP3A4—Triamcinolone—atopic dermatitis	0.0131	0.0201	CbGbCtD
Mefloquine—CYP3A4—Betamethasone—atopic dermatitis	0.0112	0.0173	CbGbCtD
Mefloquine—CYP3A4—Prednisolone—atopic dermatitis	0.0111	0.017	CbGbCtD
Mefloquine—ABCB1—Dexamethasone—atopic dermatitis	0.0109	0.0168	CbGbCtD
Mefloquine—CYP3A4—Hydrocortisone—atopic dermatitis	0.0105	0.0161	CbGbCtD
Mefloquine—CYP3A4—Prednisone—atopic dermatitis	0.0105	0.0161	CbGbCtD
Mefloquine—CYP2D6—Dexamethasone—atopic dermatitis	0.0103	0.0158	CbGbCtD
Mefloquine—HBA2—neck—atopic dermatitis	0.0083	0.11	CbGeAlD
Mefloquine—CYP3A4—Dexamethasone—atopic dermatitis	0.00653	0.01	CbGbCtD
Mefloquine—HBA1—skin of body—atopic dermatitis	0.00585	0.0776	CbGeAlD
Mefloquine—HBA2—skin of body—atopic dermatitis	0.00537	0.0713	CbGeAlD
Mefloquine—HBA1—head—atopic dermatitis	0.00382	0.0507	CbGeAlD
Mefloquine—HBA2—head—atopic dermatitis	0.0035	0.0465	CbGeAlD
Mefloquine—ADORA2A—head—atopic dermatitis	0.00182	0.0242	CbGeAlD
Mefloquine—ADORA1—head—atopic dermatitis	0.00157	0.0209	CbGeAlD
Mefloquine—BCHE—skin of body—atopic dermatitis	0.00118	0.0156	CbGeAlD
Mefloquine—CYP19A1—head—atopic dermatitis	0.00107	0.0142	CbGeAlD
Mefloquine—BCHE—head—atopic dermatitis	0.000769	0.0102	CbGeAlD
Mefloquine—CYP2D6—head—atopic dermatitis	0.00051	0.00676	CbGeAlD
Mefloquine—ADORA1—G alpha (i) signalling events—CCL27—atopic dermatitis	0.000444	0.0108	CbGpPWpGaD
Mefloquine—HBA1—Folate Metabolism—IL6—atopic dermatitis	0.000413	0.0101	CbGpPWpGaD
Mefloquine—HBA1—Selenium Micronutrient Network—TNF—atopic dermatitis	0.000406	0.00992	CbGpPWpGaD
Mefloquine—BCHE—Peptide hormone metabolism—CMA1—atopic dermatitis	0.000398	0.00972	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000396	0.00967	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Other—CXCR3—atopic dermatitis	0.000377	0.00921	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—GLB1—atopic dermatitis	0.000376	0.00919	CbGpPWpGaD
Mefloquine—ABCB1—head—atopic dermatitis	0.000367	0.00487	CbGeAlD
Mefloquine—HBA2—Metabolism—ADSL—atopic dermatitis	0.000361	0.00881	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000353	0.00862	CbGpPWpGaD
Mefloquine—HBA1—Selenium Micronutrient Network—IL6—atopic dermatitis	0.000328	0.008	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000317	0.00773	CbGpPWpGaD
Mefloquine—ADORA2A—Monoamine Transport—IL1B—atopic dermatitis	0.000316	0.00772	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000306	0.00746	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CCL22—atopic dermatitis	0.000302	0.00736	CbGpPWpGaD
Mefloquine—ADORA2A—G alpha (s) signalling events—NPS—atopic dermatitis	0.0003	0.00733	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—GLB1—atopic dermatitis	0.000285	0.00696	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—ADSL—atopic dermatitis	0.000274	0.00668	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000273	0.00665	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CCL27—atopic dermatitis	0.000269	0.00656	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—NPS—atopic dermatitis	0.000264	0.00645	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000262	0.00639	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000255	0.00623	CbGpPWpGaD
Mefloquine—ACHE—Monoamine Transport—IL1B—atopic dermatitis	0.000253	0.00617	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000244	0.00597	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000243	0.00593	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CCL17—atopic dermatitis	0.000241	0.00589	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Other—CCR5—atopic dermatitis	0.000236	0.00577	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCL22—atopic dermatitis	0.000233	0.00568	CbGpPWpGaD
Mefloquine—ADORA2A—Monoamine Transport—TNF—atopic dermatitis	0.00023	0.0056	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000229	0.00558	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000212	0.00518	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000208	0.00508	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCL27—atopic dermatitis	0.000208	0.00507	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—NPS—atopic dermatitis	0.000204	0.00498	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000197	0.00481	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CCL11—atopic dermatitis	0.000194	0.00474	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	0.00019	0.00464	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000187	0.00458	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCL17—atopic dermatitis	0.000186	0.00454	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000185	0.00453	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000185	0.00453	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000185	0.00451	CbGpPWpGaD
Mefloquine—ACHE—Monoamine Transport—TNF—atopic dermatitis	0.000183	0.00448	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000182	0.00444	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—IFNG—atopic dermatitis	0.000174	0.00424	CbGpPWpGaD
Mefloquine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000173	0.00423	CbGpPWpGaD
Mefloquine—Malaise—Triamcinolone—atopic dermatitis	0.00017	0.000729	CcSEcCtD
Mefloquine—Anxiety—Hydrocortisone—atopic dermatitis	0.00017	0.000728	CcSEcCtD
Mefloquine—Malaise—Methylprednisolone—atopic dermatitis	0.00017	0.000727	CcSEcCtD
Mefloquine—Vertigo—Triamcinolone—atopic dermatitis	0.000169	0.000726	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000169	0.000725	CcSEcCtD
Mefloquine—Syncope—Triamcinolone—atopic dermatitis	0.000169	0.000725	CcSEcCtD
Mefloquine—Vertigo—Methylprednisolone—atopic dermatitis	0.000169	0.000724	CcSEcCtD
Mefloquine—Syncope—Methylprednisolone—atopic dermatitis	0.000169	0.000723	CcSEcCtD
Mefloquine—Discomfort—Hydrocortisone—atopic dermatitis	0.000168	0.000722	CcSEcCtD
Mefloquine—Connective tissue disorder—Prednisone—atopic dermatitis	0.000168	0.000721	CcSEcCtD
Mefloquine—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000167	0.000717	CcSEcCtD
Mefloquine—Oedema—Prednisolone—atopic dermatitis	0.000167	0.000717	CcSEcCtD
Mefloquine—Vomiting—Tacrolimus—atopic dermatitis	0.000166	0.000714	CcSEcCtD
Mefloquine—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000166	0.00071	CcSEcCtD
Mefloquine—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000165	0.000709	CcSEcCtD
Mefloquine—Rash—Tacrolimus—atopic dermatitis	0.000165	0.000708	CcSEcCtD
Mefloquine—Dermatitis—Tacrolimus—atopic dermatitis	0.000165	0.000707	CcSEcCtD
Mefloquine—Shock—Prednisolone—atopic dermatitis	0.000164	0.000705	CcSEcCtD
Mefloquine—Headache—Tacrolimus—atopic dermatitis	0.000164	0.000703	CcSEcCtD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000164	0.004	CbGpPWpGaD
Mefloquine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000163	0.0007	CcSEcCtD
Mefloquine—Oedema—Hydrocortisone—atopic dermatitis	0.000163	0.0007	CcSEcCtD
Mefloquine—Convulsion—Triamcinolone—atopic dermatitis	0.000163	0.0007	CcSEcCtD
Mefloquine—Tachycardia—Prednisolone—atopic dermatitis	0.000163	0.0007	CcSEcCtD
Mefloquine—Convulsion—Methylprednisolone—atopic dermatitis	0.000163	0.000698	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—IL13—atopic dermatitis	0.000163	0.00397	CbGpPWpGaD
Mefloquine—Hypertension—Triamcinolone—atopic dermatitis	0.000163	0.000698	CcSEcCtD
Mefloquine—Hypertension—Methylprednisolone—atopic dermatitis	0.000162	0.000696	CcSEcCtD
Mefloquine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000162	0.000693	CcSEcCtD
Mefloquine—ACHE—ATF-2 transcription factor network—CXCL8—atopic dermatitis	0.000161	0.00394	CbGpPWpGaD
Mefloquine—Shock—Hydrocortisone—atopic dermatitis	0.000161	0.000689	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000161	0.00392	CbGpPWpGaD
Mefloquine—Myalgia—Triamcinolone—atopic dermatitis	0.00016	0.000688	CcSEcCtD
Mefloquine—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.00016	0.000687	CcSEcCtD
Mefloquine—Arthralgia—Methylprednisolone—atopic dermatitis	0.00016	0.000686	CcSEcCtD
Mefloquine—Myalgia—Methylprednisolone—atopic dermatitis	0.00016	0.000686	CcSEcCtD
Mefloquine—Eye disorder—Prednisone—atopic dermatitis	0.00016	0.000685	CcSEcCtD
Mefloquine—Anxiety—Methylprednisolone—atopic dermatitis	0.000159	0.000684	CcSEcCtD
Mefloquine—Tachycardia—Hydrocortisone—atopic dermatitis	0.000159	0.000683	CcSEcCtD
Mefloquine—ADORA1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000159	0.00388	CbGpPWpGaD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000159	0.000682	CcSEcCtD
Mefloquine—Flushing—Prednisone—atopic dermatitis	0.000159	0.000681	CcSEcCtD
Mefloquine—Skin disorder—Hydrocortisone—atopic dermatitis	0.000159	0.00068	CcSEcCtD
Mefloquine—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000159	0.00068	CcSEcCtD
Mefloquine—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000159	0.00068	CcSEcCtD
Mefloquine—Discomfort—Triamcinolone—atopic dermatitis	0.000158	0.00068	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—CCR3—atopic dermatitis	0.000158	0.00387	CbGpPWpGaD
Mefloquine—Discomfort—Methylprednisolone—atopic dermatitis	0.000158	0.000678	CcSEcCtD
Mefloquine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000158	0.000677	CcSEcCtD
Mefloquine—ADORA1—Circadian rythm related genes—PPARA—atopic dermatitis	0.000156	0.0038	CbGpPWpGaD
Mefloquine—Nausea—Tacrolimus—atopic dermatitis	0.000155	0.000667	CcSEcCtD
Mefloquine—Angiopathy—Prednisone—atopic dermatitis	0.000155	0.000665	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—CCL22—atopic dermatitis	0.000155	0.00378	CbGpPWpGaD
Mefloquine—Confusional state—Methylprednisolone—atopic dermatitis	0.000155	0.000663	CcSEcCtD
Mefloquine—Malaise—Dexamethasone—atopic dermatitis	0.000154	0.000661	CcSEcCtD
Mefloquine—Malaise—Betamethasone—atopic dermatitis	0.000154	0.000661	CcSEcCtD
Mefloquine—Oedema—Triamcinolone—atopic dermatitis	0.000154	0.000659	CcSEcCtD
Mefloquine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000154	0.000659	CcSEcCtD
Mefloquine—Vertigo—Dexamethasone—atopic dermatitis	0.000154	0.000659	CcSEcCtD
Mefloquine—Vertigo—Betamethasone—atopic dermatitis	0.000154	0.000659	CcSEcCtD
Mefloquine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000153	0.000658	CcSEcCtD
Mefloquine—Syncope—Betamethasone—atopic dermatitis	0.000153	0.000657	CcSEcCtD
Mefloquine—Syncope—Dexamethasone—atopic dermatitis	0.000153	0.000657	CcSEcCtD
Mefloquine—Hypotension—Hydrocortisone—atopic dermatitis	0.000153	0.000654	CcSEcCtD
Mefloquine—ADORA1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000152	0.00371	CbGpPWpGaD
Mefloquine—Shock—Triamcinolone—atopic dermatitis	0.000151	0.000649	CcSEcCtD
Mefloquine—Insomnia—Prednisolone—atopic dermatitis	0.000151	0.000649	CcSEcCtD
Mefloquine—Alopecia—Prednisone—atopic dermatitis	0.000151	0.000648	CcSEcCtD
Mefloquine—Shock—Methylprednisolone—atopic dermatitis	0.000151	0.000647	CcSEcCtD
Mefloquine—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.00015	0.000645	CcSEcCtD
Mefloquine—Loss of consciousness—Betamethasone—atopic dermatitis	0.00015	0.000644	CcSEcCtD
Mefloquine—Loss of consciousness—Dexamethasone—atopic dermatitis	0.00015	0.000644	CcSEcCtD
Mefloquine—Paraesthesia—Prednisolone—atopic dermatitis	0.00015	0.000644	CcSEcCtD
Mefloquine—Tachycardia—Triamcinolone—atopic dermatitis	0.00015	0.000644	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—CCL11—atopic dermatitis	0.00015	0.00366	CbGpPWpGaD
Mefloquine—Mental disorder—Prednisone—atopic dermatitis	0.00015	0.000643	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	0.00015	0.00366	CbGpPWpGaD
Mefloquine—Tachycardia—Methylprednisolone—atopic dermatitis	0.00015	0.000642	CcSEcCtD
Mefloquine—Skin disorder—Methylprednisolone—atopic dermatitis	0.000149	0.000639	CcSEcCtD
Mefloquine—Erythema—Prednisone—atopic dermatitis	0.000149	0.000638	CcSEcCtD
Mefloquine—Malnutrition—Prednisone—atopic dermatitis	0.000149	0.000638	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000149	0.000638	CcSEcCtD
Mefloquine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000149	0.000637	CcSEcCtD
Mefloquine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000148	0.000636	CcSEcCtD
Mefloquine—Convulsion—Betamethasone—atopic dermatitis	0.000148	0.000635	CcSEcCtD
Mefloquine—Convulsion—Dexamethasone—atopic dermatitis	0.000148	0.000635	CcSEcCtD
Mefloquine—Insomnia—Hydrocortisone—atopic dermatitis	0.000148	0.000633	CcSEcCtD
Mefloquine—Hypertension—Dexamethasone—atopic dermatitis	0.000148	0.000633	CcSEcCtD
Mefloquine—Hypertension—Betamethasone—atopic dermatitis	0.000148	0.000633	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000147	0.00359	CbGpPWpGaD
Mefloquine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000147	0.000629	CcSEcCtD
Mefloquine—Myalgia—Dexamethasone—atopic dermatitis	0.000146	0.000624	CcSEcCtD
Mefloquine—Myalgia—Betamethasone—atopic dermatitis	0.000146	0.000624	CcSEcCtD
Mefloquine—Anxiety—Dexamethasone—atopic dermatitis	0.000145	0.000622	CcSEcCtD
Mefloquine—Anxiety—Betamethasone—atopic dermatitis	0.000145	0.000622	CcSEcCtD
Mefloquine—Discomfort—Betamethasone—atopic dermatitis	0.000144	0.000617	CcSEcCtD
Mefloquine—Discomfort—Dexamethasone—atopic dermatitis	0.000144	0.000617	CcSEcCtD
Mefloquine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000144	0.000616	CcSEcCtD
Mefloquine—ADORA1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000143	0.0035	CbGpPWpGaD
Mefloquine—Hypotension—Methylprednisolone—atopic dermatitis	0.000143	0.000615	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000143	0.00349	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000143	0.00349	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—MAPK8—atopic dermatitis	0.000142	0.00347	CbGpPWpGaD
Mefloquine—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000142	0.000609	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—NPS—atopic dermatitis	0.000141	0.00345	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—TAC1—atopic dermatitis	0.000141	0.00345	CbGpPWpGaD
Mefloquine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000141	0.000605	CcSEcCtD
Mefloquine—Fatigue—Hydrocortisone—atopic dermatitis	0.000141	0.000604	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00014	0.00343	CbGpPWpGaD
Mefloquine—Vision blurred—Prednisone—atopic dermatitis	0.00014	0.000602	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.00014	0.000601	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.00014	0.000599	CcSEcCtD
Mefloquine—Anaphylactic shock—Betamethasone—atopic dermatitis	0.00014	0.000598	CcSEcCtD
Mefloquine—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.00014	0.000598	CcSEcCtD
Mefloquine—Oedema—Betamethasone—atopic dermatitis	0.00014	0.000598	CcSEcCtD
Mefloquine—Oedema—Dexamethasone—atopic dermatitis	0.00014	0.000598	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—IL5—atopic dermatitis	0.000139	0.0034	CbGpPWpGaD
Mefloquine—Insomnia—Triamcinolone—atopic dermatitis	0.000139	0.000596	CcSEcCtD
Mefloquine—Insomnia—Methylprednisolone—atopic dermatitis	0.000139	0.000595	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000138	0.00338	CbGpPWpGaD
Mefloquine—Ill-defined disorder—Prednisone—atopic dermatitis	0.000138	0.000592	CcSEcCtD
Mefloquine—Paraesthesia—Triamcinolone—atopic dermatitis	0.000138	0.000592	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—CCL27—atopic dermatitis	0.000138	0.00337	CbGpPWpGaD
Mefloquine—Feeling abnormal—Prednisolone—atopic dermatitis	0.000138	0.000591	CcSEcCtD
Mefloquine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000138	0.000591	CcSEcCtD
Mefloquine—Shock—Dexamethasone—atopic dermatitis	0.000137	0.000589	CcSEcCtD
Mefloquine—Shock—Betamethasone—atopic dermatitis	0.000137	0.000589	CcSEcCtD
Mefloquine—Dyspnoea—Triamcinolone—atopic dermatitis	0.000137	0.000588	CcSEcCtD
Mefloquine—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000137	0.000587	CcSEcCtD
Mefloquine—Nervous system disorder—Betamethasone—atopic dermatitis	0.000137	0.000587	CcSEcCtD
Mefloquine—Agitation—Prednisone—atopic dermatitis	0.000137	0.000587	CcSEcCtD
Mefloquine—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000137	0.000586	CcSEcCtD
Mefloquine—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000137	0.000586	CcSEcCtD
Mefloquine—Tachycardia—Betamethasone—atopic dermatitis	0.000136	0.000584	CcSEcCtD
Mefloquine—Tachycardia—Dexamethasone—atopic dermatitis	0.000136	0.000584	CcSEcCtD
Mefloquine—Dyspepsia—Triamcinolone—atopic dermatitis	0.000135	0.00058	CcSEcCtD
Mefloquine—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000135	0.000579	CcSEcCtD
Mefloquine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000135	0.000578	CcSEcCtD
Mefloquine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000135	0.000578	CcSEcCtD
Mefloquine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000135	0.000577	CcSEcCtD
Mefloquine—Malaise—Prednisone—atopic dermatitis	0.000134	0.000576	CcSEcCtD
Mefloquine—Vertigo—Prednisone—atopic dermatitis	0.000134	0.000574	CcSEcCtD
Mefloquine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000134	0.000573	CcSEcCtD
Mefloquine—Syncope—Prednisone—atopic dermatitis	0.000133	0.000573	CcSEcCtD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000133	0.00325	CbGpPWpGaD
Mefloquine—Urticaria—Prednisolone—atopic dermatitis	0.000133	0.00057	CcSEcCtD
Mefloquine—Fatigue—Triamcinolone—atopic dermatitis	0.000133	0.000568	CcSEcCtD
Mefloquine—Fatigue—Methylprednisolone—atopic dermatitis	0.000132	0.000567	CcSEcCtD
Mefloquine—Loss of consciousness—Prednisone—atopic dermatitis	0.000131	0.000561	CcSEcCtD
Mefloquine—Hypotension—Dexamethasone—atopic dermatitis	0.00013	0.000559	CcSEcCtD
Mefloquine—Hypotension—Betamethasone—atopic dermatitis	0.00013	0.000559	CcSEcCtD
Mefloquine—Urticaria—Hydrocortisone—atopic dermatitis	0.00013	0.000556	CcSEcCtD
Mefloquine—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000129	0.000554	CcSEcCtD
Mefloquine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000129	0.000554	CcSEcCtD
Mefloquine—Convulsion—Prednisone—atopic dermatitis	0.000129	0.000553	CcSEcCtD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000129	0.00314	CbGpPWpGaD
Mefloquine—Hypertension—Prednisone—atopic dermatitis	0.000129	0.000551	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000127	0.000545	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000127	0.000545	CcSEcCtD
Mefloquine—Myalgia—Prednisone—atopic dermatitis	0.000127	0.000544	CcSEcCtD
Mefloquine—Arthralgia—Prednisone—atopic dermatitis	0.000127	0.000544	CcSEcCtD
Mefloquine—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000127	0.000543	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000127	0.00309	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—NGF—atopic dermatitis	0.000126	0.00309	CbGpPWpGaD
Mefloquine—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000126	0.000542	CcSEcCtD
Mefloquine—Anxiety—Prednisone—atopic dermatitis	0.000126	0.000542	CcSEcCtD
Mefloquine—Insomnia—Dexamethasone—atopic dermatitis	0.000126	0.000541	CcSEcCtD
Mefloquine—Insomnia—Betamethasone—atopic dermatitis	0.000126	0.000541	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000126	0.00054	CcSEcCtD
Mefloquine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000125	0.000538	CcSEcCtD
Mefloquine—Paraesthesia—Betamethasone—atopic dermatitis	0.000125	0.000537	CcSEcCtD
Mefloquine—Paraesthesia—Dexamethasone—atopic dermatitis	0.000125	0.000537	CcSEcCtD
Mefloquine—Discomfort—Prednisone—atopic dermatitis	0.000125	0.000537	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—CCL17—atopic dermatitis	0.000124	0.00302	CbGpPWpGaD
Mefloquine—Hypersensitivity—Prednisolone—atopic dermatitis	0.000123	0.000528	CcSEcCtD
Mefloquine—Dyspepsia—Betamethasone—atopic dermatitis	0.000123	0.000527	CcSEcCtD
Mefloquine—Dyspepsia—Dexamethasone—atopic dermatitis	0.000123	0.000527	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—CCR3—atopic dermatitis	0.000122	0.00299	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—PPARA—atopic dermatitis	0.000122	0.00298	CbGpPWpGaD
Mefloquine—Urticaria—Triamcinolone—atopic dermatitis	0.000122	0.000524	CcSEcCtD
Mefloquine—Urticaria—Methylprednisolone—atopic dermatitis	0.000122	0.000523	CcSEcCtD
Mefloquine—Body temperature increased—Triamcinolone—atopic dermatitis	0.000122	0.000521	CcSEcCtD
Mefloquine—Anaphylactic shock—Prednisone—atopic dermatitis	0.000121	0.000521	CcSEcCtD
Mefloquine—Oedema—Prednisone—atopic dermatitis	0.000121	0.000521	CcSEcCtD
Mefloquine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000121	0.00052	CcSEcCtD
Mefloquine—Decreased appetite—Betamethasone—atopic dermatitis	0.000121	0.00052	CcSEcCtD
Mefloquine—Decreased appetite—Dexamethasone—atopic dermatitis	0.000121	0.00052	CcSEcCtD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000121	0.00295	CbGpPWpGaD
Mefloquine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.00012	0.000517	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.00012	0.000517	CcSEcCtD
Mefloquine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.00012	0.000516	CcSEcCtD
Mefloquine—Fatigue—Dexamethasone—atopic dermatitis	0.00012	0.000516	CcSEcCtD
Mefloquine—Fatigue—Betamethasone—atopic dermatitis	0.00012	0.000516	CcSEcCtD
Mefloquine—ADORA2A—Circadian rythm related genes—PPARA—atopic dermatitis	0.00012	0.00294	CbGpPWpGaD
Mefloquine—Shock—Prednisone—atopic dermatitis	0.00012	0.000513	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—CCL22—atopic dermatitis	0.000119	0.00292	CbGpPWpGaD
Mefloquine—Nervous system disorder—Prednisone—atopic dermatitis	0.000119	0.000511	CcSEcCtD
Mefloquine—Tachycardia—Prednisone—atopic dermatitis	0.000119	0.000509	CcSEcCtD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000118	0.00289	CbGpPWpGaD
Mefloquine—Skin disorder—Prednisone—atopic dermatitis	0.000118	0.000506	CcSEcCtD
Mefloquine—Hyperhidrosis—Prednisone—atopic dermatitis	0.000117	0.000504	CcSEcCtD
Mefloquine—ADORA2A—GPCR downstream signaling—CCL27—atopic dermatitis	0.000117	0.00286	CbGpPWpGaD
Mefloquine—Asthenia—Hydrocortisone—atopic dermatitis	0.000117	0.000502	CcSEcCtD
Mefloquine—Pruritus—Hydrocortisone—atopic dermatitis	0.000116	0.000495	CcSEcCtD
Mefloquine—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000115	0.000493	CcSEcCtD
Mefloquine—Feeling abnormal—Betamethasone—atopic dermatitis	0.000115	0.000493	CcSEcCtD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000115	0.0028	CbGpPWpGaD
Mefloquine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000114	0.000489	CcSEcCtD
Mefloquine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000114	0.000489	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000114	0.00278	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000113	0.00277	CbGpPWpGaD
Mefloquine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000113	0.000486	CcSEcCtD
Mefloquine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000113	0.000485	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000112	0.00273	CbGpPWpGaD
Mefloquine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000112	0.000479	CcSEcCtD
Mefloquine—ACHE—Metabolism of proteins—GLB1—atopic dermatitis	0.000111	0.00272	CbGpPWpGaD
Mefloquine—Urticaria—Betamethasone—atopic dermatitis	0.000111	0.000475	CcSEcCtD
Mefloquine—Urticaria—Dexamethasone—atopic dermatitis	0.000111	0.000475	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000111	0.000475	CcSEcCtD
Mefloquine—Dizziness—Prednisolone—atopic dermatitis	0.000111	0.000474	CcSEcCtD
Mefloquine—Asthenia—Triamcinolone—atopic dermatitis	0.00011	0.000473	CcSEcCtD
Mefloquine—Body temperature increased—Dexamethasone—atopic dermatitis	0.00011	0.000473	CcSEcCtD
Mefloquine—Abdominal pain—Betamethasone—atopic dermatitis	0.00011	0.000473	CcSEcCtD
Mefloquine—Body temperature increased—Betamethasone—atopic dermatitis	0.00011	0.000473	CcSEcCtD
Mefloquine—Abdominal pain—Dexamethasone—atopic dermatitis	0.00011	0.000473	CcSEcCtD
Mefloquine—Asthenia—Methylprednisolone—atopic dermatitis	0.00011	0.000472	CcSEcCtD
Mefloquine—Insomnia—Prednisone—atopic dermatitis	0.00011	0.000471	CcSEcCtD
Mefloquine—Paraesthesia—Prednisone—atopic dermatitis	0.000109	0.000468	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—TAC1—atopic dermatitis	0.000109	0.00266	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—NPS—atopic dermatitis	0.000109	0.00266	CbGpPWpGaD
Mefloquine—Pruritus—Triamcinolone—atopic dermatitis	0.000109	0.000467	CcSEcCtD
Mefloquine—Pruritus—Methylprednisolone—atopic dermatitis	0.000109	0.000465	CcSEcCtD
Mefloquine—Dizziness—Hydrocortisone—atopic dermatitis	0.000108	0.000463	CcSEcCtD
Mefloquine—Dyspepsia—Prednisone—atopic dermatitis	0.000107	0.000459	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—CXCR3—atopic dermatitis	0.000107	0.00261	CbGpPWpGaD
Mefloquine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000107	0.00261	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCL27—atopic dermatitis	0.000107	0.0026	CbGpPWpGaD
Mefloquine—Decreased appetite—Prednisone—atopic dermatitis	0.000106	0.000453	CcSEcCtD
Mefloquine—Rash—Prednisolone—atopic dermatitis	0.000105	0.000452	CcSEcCtD
Mefloquine—Dermatitis—Prednisolone—atopic dermatitis	0.000105	0.000452	CcSEcCtD
Mefloquine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000105	0.00045	CcSEcCtD
Mefloquine—Fatigue—Prednisone—atopic dermatitis	0.000105	0.000449	CcSEcCtD
Mefloquine—Headache—Prednisolone—atopic dermatitis	0.000105	0.000449	CcSEcCtD
Mefloquine—Vomiting—Hydrocortisone—atopic dermatitis	0.000104	0.000445	CcSEcCtD
Mefloquine—Rash—Hydrocortisone—atopic dermatitis	0.000103	0.000442	CcSEcCtD
Mefloquine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000103	0.000441	CcSEcCtD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000103	0.00251	CbGpPWpGaD
Mefloquine—Headache—Hydrocortisone—atopic dermatitis	0.000102	0.000439	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—IL10—atopic dermatitis	0.000102	0.00248	CbGpPWpGaD
Mefloquine—Dizziness—Triamcinolone—atopic dermatitis	0.000102	0.000436	CcSEcCtD
Mefloquine—Dizziness—Methylprednisolone—atopic dermatitis	0.000101	0.000435	CcSEcCtD
Mefloquine—Feeling abnormal—Prednisone—atopic dermatitis	0.0001	0.000429	CcSEcCtD
Mefloquine—Asthenia—Betamethasone—atopic dermatitis	0.0001	0.000429	CcSEcCtD
Mefloquine—Asthenia—Dexamethasone—atopic dermatitis	0.0001	0.000429	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—CCL11—atopic dermatitis	9.97e-05	0.00243	CbGpPWpGaD
Mefloquine—Gastrointestinal pain—Prednisone—atopic dermatitis	9.93e-05	0.000426	CcSEcCtD
Mefloquine—Nausea—Prednisolone—atopic dermatitis	9.93e-05	0.000426	CcSEcCtD
Mefloquine—BCHE—Metabolism of proteins—GLB1—atopic dermatitis	9.92e-05	0.00242	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL4—atopic dermatitis	9.9e-05	0.00242	CbGpPWpGaD
Mefloquine—Pruritus—Betamethasone—atopic dermatitis	9.87e-05	0.000423	CcSEcCtD
Mefloquine—Pruritus—Dexamethasone—atopic dermatitis	9.87e-05	0.000423	CcSEcCtD
Mefloquine—ADORA1—Signaling Pathways—FCER2—atopic dermatitis	9.83e-05	0.0024	CbGpPWpGaD
Mefloquine—Vomiting—Triamcinolone—atopic dermatitis	9.78e-05	0.000419	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	9.77e-05	0.00238	CbGpPWpGaD
Mefloquine—Vomiting—Methylprednisolone—atopic dermatitis	9.75e-05	0.000418	CcSEcCtD
Mefloquine—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	9.72e-05	0.00237	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—NGF—atopic dermatitis	9.72e-05	0.00237	CbGpPWpGaD
Mefloquine—Nausea—Hydrocortisone—atopic dermatitis	9.7e-05	0.000416	CcSEcCtD
Mefloquine—Rash—Triamcinolone—atopic dermatitis	9.69e-05	0.000416	CcSEcCtD
Mefloquine—Dermatitis—Triamcinolone—atopic dermatitis	9.69e-05	0.000415	CcSEcCtD
Mefloquine—Rash—Methylprednisolone—atopic dermatitis	9.67e-05	0.000415	CcSEcCtD
Mefloquine—Dermatitis—Methylprednisolone—atopic dermatitis	9.66e-05	0.000414	CcSEcCtD
Mefloquine—Urticaria—Prednisone—atopic dermatitis	9.65e-05	0.000414	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—CCL5—atopic dermatitis	9.64e-05	0.00235	CbGpPWpGaD
Mefloquine—Headache—Triamcinolone—atopic dermatitis	9.63e-05	0.000413	CcSEcCtD
Mefloquine—Headache—Methylprednisolone—atopic dermatitis	9.61e-05	0.000412	CcSEcCtD
Mefloquine—Abdominal pain—Prednisone—atopic dermatitis	9.6e-05	0.000412	CcSEcCtD
Mefloquine—Body temperature increased—Prednisone—atopic dermatitis	9.6e-05	0.000412	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—CCL17—atopic dermatitis	9.55e-05	0.00233	CbGpPWpGaD
Mefloquine—Diarrhoea—Betamethasone—atopic dermatitis	9.55e-05	0.000409	CcSEcCtD
Mefloquine—Diarrhoea—Dexamethasone—atopic dermatitis	9.55e-05	0.000409	CcSEcCtD
Mefloquine—HBA1—Metabolism—PPARA—atopic dermatitis	9.26e-05	0.00226	CbGpPWpGaD
Mefloquine—Dizziness—Betamethasone—atopic dermatitis	9.23e-05	0.000396	CcSEcCtD
Mefloquine—Dizziness—Dexamethasone—atopic dermatitis	9.23e-05	0.000396	CcSEcCtD
Mefloquine—ADORA1—Signaling Pathways—CCL22—atopic dermatitis	9.14e-05	0.00223	CbGpPWpGaD
Mefloquine—Nausea—Triamcinolone—atopic dermatitis	9.13e-05	0.000392	CcSEcCtD
Mefloquine—Nausea—Methylprednisolone—atopic dermatitis	9.11e-05	0.000391	CcSEcCtD
Mefloquine—ACHE—ATF-2 transcription factor network—IL6—atopic dermatitis	9.07e-05	0.00221	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CCR3—atopic dermatitis	8.95e-05	0.00219	CbGpPWpGaD
Mefloquine—Hypersensitivity—Prednisone—atopic dermatitis	8.95e-05	0.000384	CcSEcCtD
Mefloquine—Vomiting—Betamethasone—atopic dermatitis	8.87e-05	0.00038	CcSEcCtD
Mefloquine—Vomiting—Dexamethasone—atopic dermatitis	8.87e-05	0.00038	CcSEcCtD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—CASP8—atopic dermatitis	8.85e-05	0.00216	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	8.85e-05	0.00216	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	8.8e-05	0.00215	CbGpPWpGaD
Mefloquine—Rash—Dexamethasone—atopic dermatitis	8.8e-05	0.000377	CcSEcCtD
Mefloquine—Rash—Betamethasone—atopic dermatitis	8.8e-05	0.000377	CcSEcCtD
Mefloquine—Dermatitis—Dexamethasone—atopic dermatitis	8.79e-05	0.000377	CcSEcCtD
Mefloquine—Dermatitis—Betamethasone—atopic dermatitis	8.79e-05	0.000377	CcSEcCtD
Mefloquine—Headache—Betamethasone—atopic dermatitis	8.74e-05	0.000375	CcSEcCtD
Mefloquine—Headache—Dexamethasone—atopic dermatitis	8.74e-05	0.000375	CcSEcCtD
Mefloquine—Asthenia—Prednisone—atopic dermatitis	8.72e-05	0.000374	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—CCR5—atopic dermatitis	8.68e-05	0.00212	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—CXCL8—atopic dermatitis	8.67e-05	0.00212	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CXCL10—atopic dermatitis	8.64e-05	0.00211	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—MAPK8—atopic dermatitis	8.64e-05	0.00211	CbGpPWpGaD
Mefloquine—Pruritus—Prednisone—atopic dermatitis	8.6e-05	0.000369	CcSEcCtD
Mefloquine—ACHE—Metabolism of proteins—CMA1—atopic dermatitis	8.43e-05	0.00206	CbGpPWpGaD
Mefloquine—Diarrhoea—Prednisone—atopic dermatitis	8.31e-05	0.000356	CcSEcCtD
Mefloquine—Nausea—Dexamethasone—atopic dermatitis	8.29e-05	0.000355	CcSEcCtD
Mefloquine—Nausea—Betamethasone—atopic dermatitis	8.29e-05	0.000355	CcSEcCtD
Mefloquine—ADORA1—Signaling Pathways—CCL27—atopic dermatitis	8.15e-05	0.00199	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCR3—atopic dermatitis	8.13e-05	0.00198	CbGpPWpGaD
Mefloquine—Dizziness—Prednisone—atopic dermatitis	8.03e-05	0.000345	CcSEcCtD
Mefloquine—ADORA2A—Signaling by NGF—NFKBIA—atopic dermatitis	8.02e-05	0.00196	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	7.98e-05	0.00195	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—TAC1—atopic dermatitis	7.98e-05	0.00195	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—NPS—atopic dermatitis	7.98e-05	0.00195	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CXCR3—atopic dermatitis	7.83e-05	0.00191	CbGpPWpGaD
Mefloquine—Vomiting—Prednisone—atopic dermatitis	7.72e-05	0.000331	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—CCL11—atopic dermatitis	7.7e-05	0.00188	CbGpPWpGaD
Mefloquine—Rash—Prednisone—atopic dermatitis	7.66e-05	0.000329	CcSEcCtD
Mefloquine—Dermatitis—Prednisone—atopic dermatitis	7.65e-05	0.000328	CcSEcCtD
Mefloquine—Headache—Prednisone—atopic dermatitis	7.61e-05	0.000326	CcSEcCtD
Mefloquine—ADORA2A—Signaling Pathways—FCER2—atopic dermatitis	7.59e-05	0.00185	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CMA1—atopic dermatitis	7.52e-05	0.00184	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCL5—atopic dermatitis	7.44e-05	0.00182	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—IL5—atopic dermatitis	7.42e-05	0.00181	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL17—atopic dermatitis	7.31e-05	0.00178	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—NPS—atopic dermatitis	7.25e-05	0.00177	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—TAC1—atopic dermatitis	7.25e-05	0.00177	CbGpPWpGaD
Mefloquine—Nausea—Prednisone—atopic dermatitis	7.22e-05	0.000309	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—CXCR3—atopic dermatitis	7.11e-05	0.00173	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL22—atopic dermatitis	7.06e-05	0.00172	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	7.04e-05	0.00172	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CCR3—atopic dermatitis	6.91e-05	0.00169	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	6.89e-05	0.00168	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL5—atopic dermatitis	6.74e-05	0.00164	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCR5—atopic dermatitis	6.7e-05	0.00164	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—MAPK8—atopic dermatitis	6.67e-05	0.00163	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—KIF3A—atopic dermatitis	6.51e-05	0.00159	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CXCL10—atopic dermatitis	6.33e-05	0.00154	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL27—atopic dermatitis	6.29e-05	0.00154	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCR3—atopic dermatitis	6.28e-05	0.00153	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—NPS—atopic dermatitis	6.16e-05	0.0015	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—TAC1—atopic dermatitis	6.16e-05	0.0015	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCR3—atopic dermatitis	6.04e-05	0.00147	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	5.99e-05	0.00146	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL11—atopic dermatitis	5.89e-05	0.00144	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CMA1—atopic dermatitis	5.89e-05	0.00144	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CXCL10—atopic dermatitis	5.74e-05	0.0014	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GLB1—atopic dermatitis	5.73e-05	0.0014	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—IL5—atopic dermatitis	5.73e-05	0.0014	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL17—atopic dermatitis	5.64e-05	0.00138	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—NPS—atopic dermatitis	5.59e-05	0.00137	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—TAC1—atopic dermatitis	5.59e-05	0.00137	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	5.57e-05	0.00136	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	5.55e-05	0.00135	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—STAT6—atopic dermatitis	5.54e-05	0.00135	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—IL6—atopic dermatitis	5.52e-05	0.00135	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ADSL—atopic dermatitis	5.5e-05	0.00134	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCR3—atopic dermatitis	5.49e-05	0.00134	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CCL5—atopic dermatitis	5.44e-05	0.00133	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	5.34e-05	0.0013	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.32e-05	0.0013	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL2—atopic dermatitis	5.32e-05	0.0013	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GLB1—atopic dermatitis	5.27e-05	0.00129	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	5.26e-05	0.00128	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CXCL8—atopic dermatitis	5.25e-05	0.00128	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL5—atopic dermatitis	5.2e-05	0.00127	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GLB1—atopic dermatitis	5.11e-05	0.00125	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ADSL—atopic dermatitis	5.05e-05	0.00123	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—MAPK8—atopic dermatitis	5.03e-05	0.00123	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—KIF3A—atopic dermatitis	5.03e-05	0.00123	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCL5—atopic dermatitis	4.94e-05	0.00121	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CCR5—atopic dermatitis	4.91e-05	0.0012	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ADSL—atopic dermatitis	4.9e-05	0.0012	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCL10—atopic dermatitis	4.88e-05	0.00119	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCR3—atopic dermatitis	4.8e-05	0.00117	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CMA1—atopic dermatitis	4.55e-05	0.00111	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL11—atopic dermatitis	4.55e-05	0.00111	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCR5—atopic dermatitis	4.45e-05	0.00109	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL10—atopic dermatitis	4.43e-05	0.00108	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	4.39e-05	0.00107	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—TAC1—atopic dermatitis	4.28e-05	0.00104	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NPS—atopic dermatitis	4.28e-05	0.00104	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—STAT6—atopic dermatitis	4.28e-05	0.00104	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—IL6—atopic dermatitis	4.26e-05	0.00104	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CCL5—atopic dermatitis	4.2e-05	0.00103	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCR3—atopic dermatitis	4.2e-05	0.00102	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	4.18e-05	0.00102	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	4.18e-05	0.00102	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CXCL8—atopic dermatitis	4.05e-05	0.000989	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL5—atopic dermatitis	3.98e-05	0.000971	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TNF—atopic dermatitis	3.87e-05	0.000946	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	3.85e-05	0.00094	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.84e-05	0.000937	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCL5—atopic dermatitis	3.82e-05	0.000932	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CCR5—atopic dermatitis	3.79e-05	0.000925	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	3.73e-05	0.00091	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCR3—atopic dermatitis	3.71e-05	0.000905	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	3.57e-05	0.000871	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	3.47e-05	0.000848	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCR5—atopic dermatitis	3.44e-05	0.00084	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL10—atopic dermatitis	3.39e-05	0.000828	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—TAC1—atopic dermatitis	3.31e-05	0.000807	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NPS—atopic dermatitis	3.31e-05	0.000807	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCR3—atopic dermatitis	3.24e-05	0.000791	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—IL6—atopic dermatitis	3.21e-05	0.000784	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL5—atopic dermatitis	3.07e-05	0.00075	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.97e-05	0.000724	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL5—atopic dermatitis	2.92e-05	0.000713	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—IL2—atopic dermatitis	2.83e-05	0.000692	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NGF—atopic dermatitis	2.71e-05	0.00066	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CXCL8—atopic dermatitis	2.69e-05	0.000657	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCR5—atopic dermatitis	2.63e-05	0.000642	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL10—atopic dermatitis	2.62e-05	0.00064	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL2—atopic dermatitis	2.57e-05	0.000628	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GLB1—atopic dermatitis	2.5e-05	0.000609	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	2.42e-05	0.00059	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ADSL—atopic dermatitis	2.39e-05	0.000584	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GLB1—atopic dermatitis	2.35e-05	0.000574	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	2.29e-05	0.000559	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—CXCL8—atopic dermatitis	2.28e-05	0.000556	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL5—atopic dermatitis	2.26e-05	0.000551	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ADSL—atopic dermatitis	2.25e-05	0.00055	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—NFKBIA—atopic dermatitis	2.23e-05	0.000545	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—IL2—atopic dermatitis	2.19e-05	0.000534	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NGF—atopic dermatitis	2.09e-05	0.00051	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL8—atopic dermatitis	2.08e-05	0.000508	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCR5—atopic dermatitis	2.03e-05	0.000496	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—CXCL8—atopic dermatitis	2.03e-05	0.000496	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL2—atopic dermatitis	1.99e-05	0.000485	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.91e-05	0.000467	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—PPARA—atopic dermatitis	1.86e-05	0.000454	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.73e-05	0.000422	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—NFKBIA—atopic dermatitis	1.72e-05	0.00042	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—PPARA—atopic dermatitis	1.71e-05	0.000417	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—PPARA—atopic dermatitis	1.66e-05	0.000405	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL8—atopic dermatitis	1.59e-05	0.000388	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.54e-05	0.000375	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL2—atopic dermatitis	1.52e-05	0.000371	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—atopic dermatitis	1.51e-05	0.000369	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.47e-05	0.00036	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MAPK8—atopic dermatitis	1.4e-05	0.000342	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL8—atopic dermatitis	1.23e-05	0.0003	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL2—atopic dermatitis	1.17e-05	0.000287	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—atopic dermatitis	1.17e-05	0.000285	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MAPK8—atopic dermatitis	1.08e-05	0.000264	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—atopic dermatitis	8.94e-06	0.000218	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—PPARA—atopic dermatitis	8.1e-06	0.000198	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—PPARA—atopic dermatitis	7.63e-06	0.000186	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—atopic dermatitis	6.9e-06	0.000168	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—PPARA—atopic dermatitis	4.99e-06	0.000122	CbGpPWpGaD
